About NeuroBiome

Personalized Medicine
for Brain Health.

A biology-first company working at the intersection of microbiome science, artificial intelligence, and neuropsychiatric care.

Our Story

Founded in 2026

NeuroBiome is founded with a simple but powerful idea: every patient is biologically unique, and medicine should reflect that reality.

Growing scientific evidence indicates that the human microbiome plays a crucial role in health, influencing brain function, metabolism, immune responses, and even the efficacy of many medications. Yet this vast biological ecosystem remains largely untapped in clinical practice.

NeuroBiome was created to bridge this gap. By combining advances in microbiome science, bioinformatics, and precision medicine, we aim to translate microbiome data into actionable therapeutic insights that support clinicians and improve patient outcomes.

Foundational Principles

Our Values

Scientific Integrity

Evidence-based methodologies and measurable outcomes drive all R&D. We prioritize transparency and clinical validation.

Innovation with Purpose

We innovate to address unmet needs in brain health, ensuring every advancement generates tangible patient improvements.

Ethical Responsibility

Committed to data privacy and fairness, recognizing the profound implications of microbiome and AI insights.

Gut–Brain Axis

Holistic Medicine

We view the gut–brain axis as a dynamic network, embracing a systems-biology perspective of health.

Long-Term Impact

Long-Term Impact

Moving from symptom management to mechanism-based interventions for a sustainable transformation of brain health.

Our Vision

Where We're Headed

"We envision a future where the microbiome signature becomes a standard component of clinical decision-making."

In this future, treatments will no longer rely solely on generalized protocols but will instead be informed by each individual's biological ecosystem, enabling more precise, effective, and personalized healthcare.

Scientific Minds

Meet Our Team

Jessica Perego, PhD

Jessica Perego, PhD

CEO, Founder & Lead Scientist

Expert in microbiome science and neuroactive metabolites with a vision to bridge the gap between microbiome-gut-brain science and clinical neuropsychiatry.

Aurélia Martinez, MBA

Co-CEO

Financial structuring and sustainable value creation, with a focus on business development, scaling operations, clinical partnerships, investor relations and go-to-market strategy.

Bhoumik Shankar Mishra

AI/ML Developer

Artificial intelligence, machine learning and data engineering, focused on in-house model development, validation, explainability and the technical MVP.

Clinical advisor opportunity

Work with us

Help shape the clinical future of personalised brain health.

NeuroBiome is developing AI-powered, personalised microbiome-based approaches for neurological and neuropsychiatric disorders, with an initial focus on multiple sclerosis, Parkinson’s disease and Alzheimer’s disease.

Clinical Advisor — Neurology

Europe · Remote Advisory role Flexible schedule

Support the clinical development of our AI-powered platform for microbiome-informed precision medicine.

What you will contribute

  • Clinical strategy
  • Clinical validation

Your background

  • Medical degree (MD or equivalent) with specialisation in neurology or ongoing neurology residency.
  • Interest in the gut–brain axis, microbiome research and precision medicine.
  • Experience in clinical trials, translational research or AI in healthcare is a plus.

Scientific collaboration

Scientific collaboration and co-authorship opportunities.

Send your CV or LinkedIn profile to

jessica.perego@neurobiome.eu

Jessica Perego · Founder & CEO

Apply by email
Development Stage

Where We Are Now

NeuroBiome is currently in its foundational phase — building the AI platform, validating clinical protocols, and establishing early clinical partnerships. Here is our development roadmap.

Current
Foundation & Clinical Validation
2026
We are here
Next
Clinical Expansion & Data Consolidation
2027
Planned
Regulatory Advancement & Market Positioning
2028
Vision
Scalable Platform Growth
2029+